Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:
Magellan Midstream Partners (MMP) : "This one is going higher. They are doing an amazing job."
Xylem (XYL) : "This has come down but I'll reiterate my buy."
Karyopharm Therapeutics (KPTI) : "That is a very speculative situation and I cannot endorse it here."
New Residential Investment (NRZ) : "I don't know what they own and I'm taking a pass."
Kemet (KEM) : "I think this is a good one."
Iovance Biotherapeutics (IOVA) : "These are speculative, but they do tend to get takeover bids. "
Boston Scientific (BSX) : "This is an earnings story and this is a remarkable story."
Cramer and the AAP team say the Producer Price Index data point to an improving environment for Nucor (NUE) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Over on Real Money, Cramer explains why he thinks it's good that retailers are taking some hits after recent gains. Get more of his insights with a free trial subscription to Real Money.
Cramer says when you spend a whole day interviewing and listening to more than a dozen people, as he did Thursday at TheDeal's Corporate Governance conference, you can come back with a gazillion takeaways. Check out his Top Takeaways over on Real Money.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.